ASCO 2023: ADC Post-Conference Report

Beacon ADC experts have screened each abstract from the 2023 ASCO Annual Meeting, held on 2nd to 6th June. This year, 132 ADC-relevant abstracts (126 clinical and 6 preclinical) were identified and have been listed in order of presentation in our Post-Conference Report.

ASCO 2023: ADC Abstract Highlights

The ASCO Post-Conference Report sample includes additional analysis and insight from our Beacon ADC experts as well as a list of all ADC-relevant abstracts.

You May Also Be Interested In…

Learn More About ADC

What is Beacon ADC?
  • The Most Comprehensive Way to Search the ADC Drug Development Landscape: Unique search ontologies based on ADC drug and trial characteristics
  • Market Leading Approach to ADC Preclinical & Clinical Data Curation: Manual curation of key ADC research and development data points by ADC research scientists
  • Seamlessly Integrate Commercial & Scientific Data all in One Place: Search ADC company and deal data based on their pipeline and technologies.
  • Unrivalled Granularity in Reports & Analysis: Our search ontology and technology indexing enable comprehensive analysis not seen elsewhere.
Learn More About Beacon ADC Request Demo

What is Beacon?

Beacon is the essential intelligence platform for R&D decision-makers working in pharma and biotech, offering unique technology and drug datasets for complex therapeutics and disease areas.

Our market-defining proprietary ontologies, manual data curation, and accurate and comprehensive life science data, provide our customers with unparalleled visibility of the drug, trial and commercial landscape.

This is why 24 of the top 25 pharmaceutical companies trust Beacon to power their critical pipeline, competitive, and commercial decisions.

We’d welcome the opportunity to show you how Beacon can transform your data strategy. Book your personalized demonstration today!

Request Demonstration

Menu
Search Icon
Close Icon
Search